Log in or Sign up for Free to view tailored content for your specialty!
Hematology/Oncology News
VIDEO: Potential of AI in breast cancer diagnostics
In this video interview, Sara M. Tolaney, MD, MPH, highlights the integration of artificial intelligence in radiologic reads to assist technicians in detecting abnormalities during breast cancer screenings.
VIDEO: Low-dose tamoxifen reduces toxicity with ‘very robust efficacy’
In this video interview, Sara M. Tolaney, MD, MPH, highlights the efficacy of low-dose tamoxifen used for breast cancer prevention.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: How providers can ‘do better’ to improve access to care for breast cancer patients
In this video interview, Sara M. Tolaney, MD, MPH, discusses the need to address disparities among patients with breast cancer.
Mindful breathing significantly reduces pain intensity among people with cancer
A 20-minute mindful breathing session rapidly reduced pain intensity and anxiety among people with cancer, according to results of a randomized controlled study.
Severe toxicity risk from radiotherapy ‘may not be trivial’ in systemic sclerosis
Radiotherapy poses no significant risks for worsening disease in patients with systemic sclerosis, but entails “variable risk” for both acute and late toxicities, according to data published in The Journal of Rheumatology.
Despite benefits, many patients with leukemia, lymphoma do not undergo IgG tests
Many patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma do not undergo immunoglobulin G testing despite its potential to reduce likelihood of severe infections.
Women 8% less likely than men to receive a liver transplant, possibly due to candidate size
Women with hepatocellular carcinoma were less likely to receive a liver transplant and more likely to die or be removed from the waitlist vs. men, underscoring the need for changes to allocation policies, according to researchers.
Ivonescimab extends PFS vs. pembrolizumab in advanced NSCLC, may be ‘a new standard’
Ivonescimab significantly improved PFS compared with pembrolizumab as first-line treatment of PD-L1-positive advanced non-small cell lung cancer, according to results of the HARMONi-2 trial.
Perioperative nivolumab improves outcomes in resectable NSCLC
Immunotherapy before and after surgery significantly improved EFS compared with neoadjuvant immunotherapy only for patients with resectable non-small cell lung cancer, according to a comparison of results from two randomized phase 3 trials.
Despite progress, barriers to lung cancer biomarker testing persist
Acceptance and utilization of lung cancer biomarker testing has increased in the past 6 years, but key barriers persist, according to survey results.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read